GL1X · GenesisL1 explorer

Research workbench

The crystal structure of human transhydrogenase domain III with bound NADP

Analyse The crystal structure of human transhydrogenase domain III with bound NADP in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1DJL
Type
protein
Length
364 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2
Source
Homo sapiens
Molecule
Transhydrogenase diii
EC
1.6.1.1
UniProt
Q13423
Ligands
NAP, SO4
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · resolution 2 · 1 distinct chain · 42% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTranshydrogenase diii (EC 1.6.1.1)protein18242% helix, 18% strandQ13423

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12250.570.7932NAP, GOL
22120.550.7833NAP, GOL
32050.460.7427empty

Interfaces

1 interface between chains.

  • A–B · 36 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 1DJL · The crystal structure of human transhydrogenase domain III with bound NADP · the same entry in another collection · chain A against A, TM-score 1.00
  • Q13423 · AlphaFold monomer V2.0 prediction for NAD(P) transhydrogenase, mitochondrial (Q13423) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.